The HCB-IDIBAPS Biobank has obtained ISO 20387 accreditation, an international standard specifically designed for biobanks that certifies technical...
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Can...
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital...
The Biobank makes more than 863,000 samples from over 56,000 different donors available to internal and external researchers.
The Catalan Tumour Bank Network (XBTC) has renewed its corporate identity and website to project a more dynamic and local network in the biomedicin...
Last Tuesday, 10 October 2023, IDIBAPS received a visit from a dozen patients with liver cancer under treatment at the Hospital Clínic. The aim was...
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various serv...
It currently contains a conservation fund of more than 250,000 nervous tissue samples that allows researchers to study a wide range of neurodegener...
The visit forms part of the knowledge exchange activities between institutions participating in the STEPUPIORS European project.
On Tuesday, 17 January 2023, the IDIBAPS auditorium was the venue for the Second Conference on Good Practice of the Network of Tumour Banks of Cata...
